Drug Supply Articles & Analysis
10 news found
DDC is an annual event that gathers researchers, scientists, and experts from across the globe who are involved in the dynamic field of drug discovery. DDC builds a perfect bridge for thought-sharing and networking, reputed to be a must-attend conference for everyone in the drug discovery industry. ...
” Under the terms of the agreement, Merck KGaA, Darmstadt, Germany will provide cetuximab clinical drug supply in all countries outside of the U.S. and Canada for AVEO’s future registrational study, which will assess ficlatuzumab with cetuximab in HPV negative R/M HNSCC. ...
Such problems include limited transparency and missing information, the lack of immediate centralized visibility, time-consuming excursion management and slow decision making, time-consuming data consolidation for audits, wastage of drugs, and patient rescheduling or lost. Through this partnership, endpoint and Berlinger can provide Sponsors with a fully integrated solution, ...
This ecosystem approach realizes the full potential of critical functions such as telehealth visits and direct-to-patient/home health shipping of study drugs, all while maintaining mission-critical goals of high patient engagement, compliance, and retention. ...
Collaboration to focus on establishing supply chain and securing distribution channels for delivering rare disease therapies to patients across China BOSTON, Mass. and SHANGHAI, China, April 19, 2021 – Citrine Medicine, a China-based rare disease therapeutics company, and Sinopharm Group, a Chinese pharmaceutical company, today announced a strategic partnership to ...
endpoint Clinical, the leading global interactive response technology (IRT®) company, and McCreadie Group, the market leader in automating manual processes in Investigational Drug Services (IDS), have collaborated to increase study product accountability transparency for study sponsors, reduce site burdens associated with clinical study IMP management, and improve related ...
Several weeks ago, the company received official authorization from the U.S. Food & Drug Administration to supply its face shields specifically to healthcare workers fighting COVID-19. ...
The T3 Verification process gives pharmacies maximum visibility to all T3 transactions, both electronic and paper, received by their pharmacy. Under the Drug Supply Chain Security Act (DSCSA), health system pharmacies are required to receive, verify, and validate that they have complete transaction information, transaction history, transaction statement or T3 ...
The FDA recently issued a draft guidance regarding verification* systems in accordance with the Drug Supply Chain Security Act (DSCSA). The purpose of the guidance was to assist the industry in understanding what requirements need to be met in a variety of situations. ...
As many doctors are hesitant to start patients on ARVs without evidence that their CD4 counts have dropped below 250 - the threshold for treatment initiation in Mozambique - the faster results mean quicker access to the life-prolonging drugs. Currently, the CD4 count machines cost about US$5,000 each. ...